Vanderbilt Heart and Vascular Institute — Nashville, Tennessee

Vanderbilt Heart and Vascular Institute is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt Heart and Vascular Institute has participated in 14 clinical trials with 2 currently active.

Therapeutic areas: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM), Schizophrenia, Peripheral Arterial Disease.

Sponsors: Ionis Pharmaceuticals, Inc., Sumitomo Pharma America, Inc., TheraVasc Inc..

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Heart and Vascular Institute?

Vanderbilt Heart and Vascular Institute has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Heart and Vascular Institute conducted?

Vanderbilt Heart and Vascular Institute has 14 clinical trials on record, with 2 currently active. Their work covers Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM), Schizophrenia, Peripheral Arterial Disease.

Is Vanderbilt Heart and Vascular Institute accredited by Crixeo Clinical Trials?

Vanderbilt Heart and Vascular Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Heart and Vascular Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.